QQCWB

GV

Advances In Insulin Pump Infusion Sets Symposium Report

Di: Ava

Rispetto al set di infusione MiniMedTM Quick-Set Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. d wear infusio et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Dia tes Science and Technol

MEDTRONIC EXTENDED INFUSIONSSET

Medtronic | Innovation in Medical Technology & Diabetes Care | Binson's

Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that is

February 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Medtronic Data on File. Minimed™ Mio™ Advance US Pivotal Trials. 152 Patients interviewed. 2020 Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Fusselman H, et al. FUSS2015D-P – The Extended Wear Infusion Set – A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020.

Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080

Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Fusselman H, et al. FUSS2015D-P – The Extended Wear Infusion Set – A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020.

Key Points There is an unmet need for longer insulin infusion set wear duration in pump users Today we are sharing some of the key exploratory pump system outcomes of the pivotal trial with Medtronic Extended Infusion Set. The results of the trial demonstrate that the device met the safety endpoints of the study in the hybrid closed loop system. Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that

Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Advances in Insulin Pump Infusion Sets Symposium Report . Journal of Diabetes Science and Technology, (), –. doi:10.1177/1932296821999080 10.1002/abio.370040210 url to share this paper: An interview with Sci-Hub Founder Alexandra Elbakyan Who exactly should pay for academic research

Important Safety Information Infusion sets are indicated for the subcutaneous infusion of medication, including insulin, from infusion pumps. See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative

Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 REFERENCES: 1. Ilany J, et al. Abstract 416 – Clinical study of a new ExtendedTM wear infusion set design. 13th ATTD International Conference. February 2020. 2. Medtronic Data on File. MinimedTM MioTM Advance US Pivotal Trials. 152 Patients interviewed. 2020. 3. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. J Diabetes Sci Technol. To discuss barriers to insulin pump therapy and present information about advancements in, and results from clinical trials of extended wear IISs, Diabetes Technology Society virtually hosted the “Improving the Patient Experience with Longer Wear Infusion Sets Symposium” on December 1, 2021.

February 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Medtronic Data on File. Minimed™ Mio™ Advance US Pivotal Trials. 152 Patients interviewed. 2020 Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that

Zhang G, et al. 986-P -Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that

DUBLIN, April 14, 2021 / PRNewswire (opens new window) / — Medtronic plc (opens new window) (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days. An infusion set is tubing that delivers insulin from the pump to the body and Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that

infusion set | Medtronic Diabetes

Abstract Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that

Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080

To discuss recent developments in, and future plans for IIS development, Diabetes Technology Society virtually hosted the Advances in Insulin Pump Infusion Sets Symposium on December 1, 2020.

Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Fusselman H, et al. FUSS2015D-P – The Extended Wear Infusion Set – A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020. Automated insulin delivery (AID) systems have revolutionized diabetes care by integrating continuous glucose monitoring, insulin pumps, and advanced algorithms to improve glycemic outcomes and reduce user burden. Early commercial AID systems were developed with a conservative approach, prioritizing safety and regulatory approval over full automation or

Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an insulin infusion set (IIS), which delivers insulin via a thin flexible plastic tube to the patient’s body via a cannula or needle that To optimise insulin absorption, reduce insulin degradation and prevent set obstruction, change your Medtronic Extended infusion set and reservoir up to every 7 days, or as per your healthcare professional’s instructions 7. When using Medtronic Extended, the set change alarm of the pump should be turned off to avoid confusion.

Zhang G, et al. 986-P – Assessment of adhesive patches for an extended wear infusion set. 80th ADA International Conference, June 2020. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080

SARNATH CHATTARAJ’s 16 research works with 56 citations and 423 reads, including: Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review Introduction Automated insulin delivery (AID) has become a well-known research topic devoted to achieving better glycemic outcomes. AID systems consist primarily of three components: the continuous glucose monitoring system, the insulin delivery system, either tethered or patch pump, and the control system (algorithm). A key component in the tethered The Extended™ infusion set and Extended™ reservoir is the only available infusion set which allows up to 7-days wear.* Use exclusively with the Extended™ reservoir. Compatible with the MiniMed™ 780G, 770G and 670G insulin pumps.

Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080 Fusselman H, et al. FUSS2015D-P – The Extended Wear Infusion Set – A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020. REFERENCES: 1. Ilany J, et al. Abstract 416 – Clinical study of a new ExtendedTM wear infusion set design. 13th ATTD International Conference. February 2020. 2. Medtronic Data on File. MinimedTM MioTM Advance US Pivotal Trials. 152 Patients interviewed. 2020. 3. Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. J Diabetes Sci Technol. Wichtige Sicherheitshinweise Infusionssets sind zur subkutanen Infusion von Arzneimitteln (einschließlich Insulin) mithilfe von Infusionspumpen indiziert. Detaillierte Informationen über Bedienungshinweise, Indikationen, Kontraindikationen, Warnhinweise, Vorsichtsmaßnahmen und mögliche Komplikationen sind dem Produkthandbuch zu entnehmen. Weitere Informationen

[3] Zhang JY, et al. Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology 2021; DOI: 10.1177/1932296821999080. [4]Medtronic Data on File. Minimed (TM) Mio (TM) Advance US Pivotal Trials. 152 Patients interviewed. 2020 Older research outputs will score higher simply because they’ve had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,514 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries .